{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cordia verbenacea", "antiglycation activity", "brickellin", "cordialin A", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36830081", "DateRevised": {"Year": "2023", "Month": "02", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "19"}], "Language": ["eng"], "ELocationID": ["522", "10.3390/antiox12020522"], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "12", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "19"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "In Vitro Antiglycation Potential of Erva-Baleeira (<i>Varronia curassavica</i> Jacq.).", "Abstract": {"AbstractText": ["<i>Varronia curassavica</i> Jacq. (Boraginaceae) is traditionally used in the treatment of inflammatory processes. The ethanolic extract of its leaves (EEVc) showed anti-inflammatory properties and low toxicity. Medicinal plants have aroused interest for their antiglycation activities. The formation and accumulation of advanced glycation end products (AGEs) are associated with several chronic diseases. The objective of this study was to evaluate the antiglycation potential of EEVc and two isolated compounds.", "The compounds brickellin and cordialin A were obtained by chromatographic methods and identified by spectrometric techniques. Analysis of fluorescent AGEs, biomarkers of amino acid residue oxidation, protein carbonyl groups and crosslink formation were performed in samples obtained from an in vitro model system of protein glycation with methylglyoxal.", "EEVc, brickellin and cordialin A significantly reduced the in vitro formation of AGEs, and reduced the damage caused by oxidative damage to the protein.", "According to the results, EEVc, brickellin and cordialin A are potential candidates against AGEs formation, which opens the way to expand the therapeutic arsenal for many pathologies resulting from glycoxidative stress."]}, "AuthorList": [{"Identifier": ["0000-0001-7760-7060"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drugs and Medicines, School of Pharmaceutical Sciences, S\u00e3o Paulo State University, Araraquara 14800-903, Brazil."}], "LastName": "Rodrigues", "ForeName": "Winner Duque", "Initials": "WD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Analysis, School of Pharmaceutical Sciences, S\u00e3o Paulo State University, Araraquara 14800-903, Brazil."}], "LastName": "Cardoso", "ForeName": "Felipe Nunes", "Initials": "FN"}, {"Identifier": ["0000-0003-0987-5295"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Analysis, School of Pharmaceutical Sciences, S\u00e3o Paulo State University, Araraquara 14800-903, Brazil."}], "LastName": "Baviera", "ForeName": "Amanda Martins", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drugs and Medicines, School of Pharmaceutical Sciences, S\u00e3o Paulo State University, Araraquara 14800-903, Brazil."}], "LastName": "Dos Santos", "ForeName": "Andr\u00e9 Gonzaga", "Initials": "AG"}], "GrantList": [{"GrantID": "GM 131110/2020-9", "Agency": "National Council for Scientific and Technological Development", "Country": ""}, {"GrantID": "465637/2014-0", "Agency": "National Institute of Science and Technology on Biodiversity and Natural Products", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83:770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Lorenzi H., Matos F.J.A. Plantas Medicinais no Brasil: Nativas e Ex\u00f3ticas. Volume 1. Instituto Plantarum; Nova Odessa, Brazil: 2002. p. 100."}, {"Citation": "de Carvalho P.M., Jr., Rodrigues R.F.O., Sawaya A.C.H.F., Marques M.O.M., Shimizu M.T. Chemical composition and antimicrobial activity of the essential oil of Cordia verbenacea D.C. J. Ethnopharmacol. 2004;95:297\u2013301. doi: 10.1016/j.jep.2004.07.028.", "ArticleIdList": ["10.1016/j.jep.2004.07.028", "15507352"]}, {"Citation": "Passos G.F., Fernandes E.S., da Cunha F.M., Ferreira J., Pianowski L.F., Campos M.M., Calixto J.B. Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from Cordia verbenacea. J. Ethnopharmacol. 2006;110:323\u2013333. doi: 10.1016/j.jep.2006.09.032.", "ArticleIdList": ["10.1016/j.jep.2006.09.032", "17084568"]}, {"Citation": "BRASIL Minist\u00e9rio da Sa\u00fade. Secretaria de Ci\u00eancia, Tecnologia e Insumos Estrat\u00e9gicos, Departamento de Assist\u00eancia Farmac\u00eautica . Pol\u00edtica Nacional de Plantas Medicinais e Fitoter\u00e1picos. Minist\u00e9rio da Sa\u00fade; Bras\u00edlia, Brazil: 2006."}, {"Citation": "BRASIL Minist\u00e9rio da Sa\u00fade. Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) Formul\u00e1rio de Fitoter\u00e1picos da Farmacopeia Brasileira. 2nd ed. Minist\u00e9rio da Sa\u00fade; Bras\u00edlia, Brazil: 2021. p. 57."}, {"Citation": "Serti\u00e9 J.A., Basile A.C., Panizza S., Matida A.K., Zelnik R. Pharmacological assay of Cordia verbenacea. Part 1. Anti-inflammatory activity and toxicity of the crude extract of the leaves. Planta Med. 1988;54:7\u201310. doi: 10.1055/s-2006-962318.", "ArticleIdList": ["10.1055/s-2006-962318", "3375340"]}, {"Citation": "Serti\u00e9 J.A.A., Basile A.C., Panizza S., Oshiro T.T., Azzolini C.P., Penna S.C. Pharmacological assay of Cordia verbenacea III: Oral and topical antiinflammatory activity and gastrotoxicity of a crude leaf extract. J. Ethnopharmacol. 1991;31:239\u2013247. doi: 10.1016/0378-8741(91)90008-2.", "ArticleIdList": ["10.1016/0378-8741(91)90008-2", "2023431"]}, {"Citation": "de Freitas Rold\u00e3o E., Witaicenis A., Seito L.N., Hiruma-Lima C.A., Di Stasi L.C. Evaluation of the antiulcerogenic and analgesic activities of Cordia verbenacea DC. (Boraginaceae) J. Ethnopharmacol. 2008;119:94\u201398. doi: 10.1016/j.jep.2008.06.001.", "ArticleIdList": ["10.1016/j.jep.2008.06.001", "18588967"]}, {"Citation": "Santi M.M., Sanches F.S., Silva J.F.M., Santos P.M.L. Determina\u00e7\u00e3o do perfil fitoqu\u00edmico de extrato com atividade antioxidante da esp\u00e9cie medicinal Cordia verbenacea DC. por HPLC-DAD. Rev. Bras. De Plantas Med. 2014;16:256\u2013261. doi: 10.1590/S1516-05722014000200014.", "ArticleIdList": ["10.1590/S1516-05722014000200014"]}, {"Citation": "Serti\u00e9 J.A.A., Woisky R.G., Wiezel G., Rodrigues M. Pharmacological assay of Cordia verbenacea V: Oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. Phytomedicine. 2005;12:338\u2013344. doi: 10.1016/j.phymed.2003.09.013.", "ArticleIdList": ["10.1016/j.phymed.2003.09.013", "15957367"]}, {"Citation": "Martim J.K.P., Maranho L.T., Costa-Casagrande T.A. Role of the chemical compounds present in the essential oil and in the extract of Cordia verbenacea DC as an anti-inflammatory, antimicrobial and healing product. J. Ethnopharmacol. 2021;265:113300. doi: 10.1016/j.jep.2020.113300.", "ArticleIdList": ["10.1016/j.jep.2020.113300", "32871237"]}, {"Citation": "Recio M.C., Andujar I., L Rios J. Anti-inflammatory agents from plants: Progress and potential. Curr. Med. Chem. 2012;19:2088\u20132103. doi: 10.2174/092986712800229069.", "ArticleIdList": ["10.2174/092986712800229069", "22414101"]}, {"Citation": "Kumar S., Bajwa B.S., Kuldeep S., Kalia A.N. Anti-inflammatory activity of herbal plants: A review. Int. J. Adv. Pharm., Biol. Chem. 2013;2:272\u2013281."}, {"Citation": "Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428\u2013435. doi: 10.1038/nature07201.", "ArticleIdList": ["10.1038/nature07201", "18650913"]}, {"Citation": "Khan M., Liu H., Wang J., Sun B. Inhibitory effect of phenolic compounds and plant extracts on the formation of advance glycation end products: A comprehensive review. Food Res. Int. 2020;130:108933. doi: 10.1016/j.foodres.2019.108933.", "ArticleIdList": ["10.1016/j.foodres.2019.108933", "32156381"]}, {"Citation": "Aajith T., Vinodkumar P. Advanced glycation end products: Association with the pathogenesis of diseases and the current therapeutic advances. Curr. Clin. Pharmacol. 2016;11:118\u2013127. doi: 10.2174/1574884711666160511150028.", "ArticleIdList": ["10.2174/1574884711666160511150028", "27164965"]}, {"Citation": "Zeng C., Li Y., Ma J., Niu L., Tay F.R. Clinical/translational aspects of advanced glycation end-products. Trends Endocrinol. Metab. 2019;30:959\u2013973. doi: 10.1016/j.tem.2019.08.005.", "ArticleIdList": ["10.1016/j.tem.2019.08.005", "31597608"]}, {"Citation": "Jahan H., Choudhary M.I. Glycation, carbonyl stress and AGEs inhibitors: A patent review. Expert Opin. Ther. Pat. 2015;25:1267\u20131284.", "ArticleIdList": ["26293545"]}, {"Citation": "Van Putte L., De Schrijver S., Moortgat P. The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: A systematic review. Scars Burn. Heal. 2016;2:2059. doi: 10.1177/2059513116676828.", "ArticleIdList": ["10.1177/2059513116676828", "PMC5965313", "29799552"]}, {"Citation": "Zieman S.J., Kass D.A. Advanced glycation end products cross-linking: Pathophysiologic role and therapeutic target in cardiovascular disease. Congest. Heart Fail. 2004;10:144\u2013151. doi: 10.1111/j.1527-5299.2004.03223.x.", "ArticleIdList": ["10.1111/j.1527-5299.2004.03223.x", "15184729"]}, {"Citation": "Nemet I., Strauch C.M., Monnier V.M. Favored and disfavored pathways of protein crosslinking by glucose: Glucose lysine dimer (GLUCOLD) and crossline versus glucosepane. Amino Acids. 2011;40:167\u2013181. doi: 10.1007/s00726-010-0631-2.", "ArticleIdList": ["10.1007/s00726-010-0631-2", "PMC2972412", "20607325"]}, {"Citation": "Chaudhuri J., Bains Y., Guha S., Kahn A., Hall D., Bose N., Gugliucci A., Kapahi P. The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality. Cell Metab. 2018;28:337\u2013352. doi: 10.1016/j.cmet.2018.08.014.", "ArticleIdList": ["10.1016/j.cmet.2018.08.014", "PMC6355252", "30184484"]}, {"Citation": "Thornalley P.J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 2003;419:31\u201340. doi: 10.1016/j.abb.2003.08.013.", "ArticleIdList": ["10.1016/j.abb.2003.08.013", "14568006"]}, {"Citation": "Yeh W.J., Hsia S.M., Lee W.H., Wu C.H. Polyphenols with antiglycation activity and mechanisms of action: A review of recent findings. J. Food Drug Anal. 2017;25:84\u201392. doi: 10.1016/j.jfda.2016.10.017.", "ArticleIdList": ["10.1016/j.jfda.2016.10.017", "PMC9333423", "28911546"]}, {"Citation": "Dos Santos C.H.C., Talpo T.C., Motta B.P., Kaga A.K., Baviera A.M., Castro R.N., da Silva V.C., de Sousa-Junior P.T., Wessjohann L., de Carvalho M.G. New compounds of Siolmatra brasiliensis and inhibition of in vitro protein glycation damage. Fitoterapia. 2019;133:109\u2013119. doi: 10.1016/j.fitote.2018.12.023.", "ArticleIdList": ["10.1016/j.fitote.2018.12.023", "30605782"]}, {"Citation": "Sadowska-Bartosz I., Galiniak S., Bartosz G. Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds. Molecules. 2014;19:4880\u20134896. doi: 10.3390/molecules19044880.", "ArticleIdList": ["10.3390/molecules19044880", "PMC6271924", "24747646"]}, {"Citation": "S\u00e9ro L., Sanguinet L., Blanchard P., Dang B.T., Morel S., Richomme P., S\u00e9raphin D., Derbr\u00e9 S. Tuning a 96-well microtiter plate fluorescence-based assay to identify age inhibitors in crude plant extracts. Molecules. 2013;18:14320\u201314339. doi: 10.3390/molecules181114320.", "ArticleIdList": ["10.3390/molecules181114320", "PMC6270619", "24256925"]}, {"Citation": "Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1994;186:346\u2013357.", "ArticleIdList": ["1978225"]}, {"Citation": "Meeprom A., Sompong W., Chan C.B., Adisakwattana S. Isoferulic acid, a new anti-glycation agent, inhibits fructose-and glucose-mediated protein glycation in vitro. Molecules. 2013;18:6439\u20136454. doi: 10.3390/molecules18066439.", "ArticleIdList": ["10.3390/molecules18066439", "PMC6270372", "23722732"]}, {"Citation": "Motta B.P., Kaga A.K., Oliveira J.O., Inacio M.D., da Silva C.F., de Sousa Junior P.T., Brunetti I.L., Baviera A.M. In vitro inhibition of protein glycation and advanced glycation end products formation by hydroethanolic extract and two fractions of Simaba trichilioides roots. Nat. Prod. Res. 2020;34:2389\u20132393. doi: 10.1080/14786419.2018.1537276.", "ArticleIdList": ["10.1080/14786419.2018.1537276", "30582373"]}, {"Citation": "Pereira J.A.S. Ph.D. Thesis. Faculdade de Ci\u00eancias Farmac\u00eauticas, UNESP; Araraquara, Brazil: 2017. Avalia\u00e7\u00e3o da Variabilidade do Metabolismo Secund\u00e1rio de Cordia verbenacea DC."}, {"Citation": "Roberts M.F., Timmermann B.N., Mabry T.J., Brown R., Matlin S.A. Brickellin, a novel flavone from Brickellia veronicaefolia and B. chlorolepis. Phytochemistry. 1984;23:163\u2013165. doi: 10.1016/0031-9422(84)83099-X.", "ArticleIdList": ["10.1016/0031-9422(84)83099-X"]}, {"Citation": "IINUMA M., MATOBA Y., TANAKA T., MIZUNO M. Flavonoids synthesis. I.: Synthesis and spectroscopic properties of flavones with two hydroxy and five methoxy groups at C-2\u2019, 3\u2019, 4\u2019, 5, 6, 6\u2019, 7 and C-2\u2019, 3, 4\u2019, 5, 5\u2019, 6, 7. Chem. Pharm. Bull. 1986;34:1656\u20131662. doi: 10.1248/cpb.34.1656.", "ArticleIdList": ["10.1248/cpb.34.1656"]}, {"Citation": "Muschietti L., Martino V., Ferraro G., Coussio J. 5, 7, 5\u2032-trihydroxy-3, 6, 2\u2032, 4\u2032-tetramethoxyflavone from Eupatorium buniifolium. Phytochemistry. 1994;36:1085\u20131086. doi: 10.1016/S0031-9422(00)90499-0.", "ArticleIdList": ["10.1016/S0031-9422(00)90499-0"]}, {"Citation": "Velde V.V., Lavie D., Zelnik R., Matida A.K., Panizza S. Cordialin A and B, two new triterpenes from Cordia verbenacea DC. J. Chem. Soc., Perkin Trans. 1982;1:2697\u20132700. doi: 10.1039/p19820002697.", "ArticleIdList": ["10.1039/p19820002697"]}, {"Citation": "Silverstein R.M., Bassler G.C. Spectrometric Identification of Organic Compounds, 7rd ed. John Wiley & Sons, Inc.; New York, NY, USA: 2005. pp. 82\u2013108."}, {"Citation": "Chinchansure A.A., Korwar A.M., Kulkarni M.J., Joshi S.P. Recent development of plant products with anti-glycation activity: A review. RSC Adv. 2015;5:31113\u201331138. doi: 10.1039/C4RA14211J.", "ArticleIdList": ["10.1039/C4RA14211J"]}, {"Citation": "Arasteh A., Farahi S., Habibi-Rezaei M., Moosavi-Movahedi A.A. Glycated albumin: An overview of the in vitro models of an in vivo potential disease marker. J. Diabetes Metab. Disord. 2014;13:49. doi: 10.1186/2251-6581-13-49.", "ArticleIdList": ["10.1186/2251-6581-13-49", "PMC4000144", "24708663"]}, {"Citation": "Atchade T., Dabole B., Adhikari A., Khan A., Mbafor J., Choudhary M. Chemical constituents of Cordia platythyrsa and evaluation of their glycation and urease inhibition activities. Nat. Prod. 2012;8:346\u2013351."}, {"Citation": "Al-Musayeib N., Perveen S., Fatima I., Nasir M., Hussain A. Antioxidant, anti-glycation and anti-inflammatory activities of phenolic constituents from Cordia sinensis. Molecules. 2011;16:10214\u201310226. doi: 10.3390/molecules161210214.", "ArticleIdList": ["10.3390/molecules161210214", "PMC6264710", "22158590"]}, {"Citation": "Lins A.P., Alvarenga M.A., Gottlieb O.R., Oliveira F. Two flavonois from Cordia verbenacea. Rev. Lat. Am. Qu\u00edmica. 1990;21:82."}, {"Citation": "Bayeux M.C., Fernandes A.T., Foglio M.A., Carvalho J.E. Evaluation of the antiedematogenic activity of artemetin isolated from Cordia curassavica DC. Braz. J. Med. Biol. Res. 2002;35:1229\u20131232. doi: 10.1590/S0100-879X2002001000017.", "ArticleIdList": ["10.1590/S0100-879X2002001000017", "12424497"]}, {"Citation": "Ticli F.K., Hage L.I., Cambraia R.S., Pereira P.S., Magro \u00c2.J., Fontes M.R., St\u00e1beli R.G., Giglio J.R., Fran\u00e7a S.C., Soares A.M., et al. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): Antiserum action potentiation and molecular interaction. Toxicon. 2005;46:318\u2013327. doi: 10.1016/j.toxicon.2005.04.023.", "ArticleIdList": ["10.1016/j.toxicon.2005.04.023", "15992846"]}, {"Citation": "Lameira O.A., Pinto J.E.B.P., Cardoso M.G., Arrigoni-Blank M.F. Estabelecimento de cultura de c\u00e9lulas em suspens\u00e3o e identifica\u00e7\u00e3o de flavon\u00f3ides em Cordia verbenacea DC. Rev. Bras. Plantas Med. 2009;11:7\u201311. doi: 10.1590/S1516-05722009000100002.", "ArticleIdList": ["10.1590/S1516-05722009000100002"]}, {"Citation": "Matias E.F.F., Alves E.F., Santos B.S., Sobral de Souza C.E., Alencar Ferreira J.V.D., Santos de Lavor A.K.L., Figueredo F.G., Ferreira de Lima L., Vieira dos Santos F.A., Neves Peixoto F.S., et al. Biological activities and chemical characterization of Cordia verbenacea DC. as tools to validate the ethnobiological usage. Evid. Based Complement. Altern. Med. 2013;2013:164215. doi: 10.1155/2013/164215.", "ArticleIdList": ["10.1155/2013/164215", "PMC3684094", "23818919"]}, {"Citation": "Matias E.F., Santos K.K., Falc\u00e3o-Silva V.S., Siqueira-J\u00fanior J.P., Costa J.G., Coutinho H.D. Modulation of the norfloxacin resistance in Staphylococcus aureus by Cordia verbenaceae DC. Indian J. Med. Res. 2013;137:178.", "ArticleIdList": ["PMC3657884", "23481069"]}, {"Citation": "Oza M.J., Kulkarni Y.A. Traditional uses, phytochemistry and pharmacology of the medicinal species of the genus Cordia (Boraginaceae) J. Pharm. Pharmacol. 2017;69:755\u2013789. doi: 10.1111/jphp.12715.", "ArticleIdList": ["10.1111/jphp.12715", "28266011"]}, {"Citation": "Rohn S. Possibilities and limitations in the analysis of covalent interactions between phenolic compounds and proteins. Food Res. Int. 2014;65:13\u201319. doi: 10.1016/j.foodres.2014.05.042.", "ArticleIdList": ["10.1016/j.foodres.2014.05.042"]}, {"Citation": "Poulsen M.W., Hedegaard R.V., Andersen J.M., de Courten B., B\u00fcgel S., Nielsen J., Skibsted L.H., Dragsted L.O. Advanced glycation endproducts in food and their effects on health. Food Chem. Toxicol. 2013;60:10\u201337. doi: 10.1016/j.fct.2013.06.052.", "ArticleIdList": ["10.1016/j.fct.2013.06.052", "23867544"]}, {"Citation": "Matsuda H., Wang T., Managi H., Yoshikawa M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 2003;11:5317\u20135323. doi: 10.1016/j.bmc.2003.09.045.", "ArticleIdList": ["10.1016/j.bmc.2003.09.045", "14642575"]}, {"Citation": "Gonz\u00e1lez I., Morales M.A., Rojas A. Polyphenols and AGEs/RAGE axis. Trends and challenges. Food Res. Int. 2020;129:108843. doi: 10.1016/j.foodres.2019.108843.", "ArticleIdList": ["10.1016/j.foodres.2019.108843", "32036875"]}, {"Citation": "Xie Y., Chen X. Structures required of polyphenols for inhibiting advanced glycation end products formation. Curr. Drug Metab. 2013;14:414\u2013431. doi: 10.2174/1389200211314040005.", "ArticleIdList": ["10.2174/1389200211314040005", "23330933"]}, {"Citation": "Yin M. Anti-glycative potential of triterpenes: A mini-review. BioMedicine. 2012;2:2\u20139. doi: 10.1016/j.biomed.2011.12.001.", "ArticleIdList": ["10.1016/j.biomed.2011.12.001"]}, {"Citation": "Motomura K., Fujiwara Y., Kiyota N., Tsurushima K., Takeya M., Nohara T., Nagai R., Ikeda T. Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products. J. Agric. Food Chem. 2009;57:7666\u20137672. doi: 10.1021/jf9007168.", "ArticleIdList": ["10.1021/jf9007168", "19681610"]}, {"Citation": "Liu Y., Hartley D.P., Liu J. Protection against carbon tetrachloride hepatotoxicity by oleanolic acid is not mediated through metallothionein. Toxicol. Lett. 1998;95:77\u201385. doi: 10.1016/S0378-4274(98)00009-5.", "ArticleIdList": ["10.1016/S0378-4274(98)00009-5", "9635410"]}, {"Citation": "Yamaguchi Y., Yamada K., Yoshikawa N., Nakamura K., Haginaka J., Kunitomo M. Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci. 2006;79:2474\u20132479. doi: 10.1016/j.lfs.2006.08.007.", "ArticleIdList": ["10.1016/j.lfs.2006.08.007", "16959274"]}, {"Citation": "Frandsen J., Narayanasamy P. Flavonoid enhances the glyoxalase pathway in cerebellar neurons to retain cellular functions. Sci. Rep. 2017;7:5126. doi: 10.1038/s41598-017-05287-z.", "ArticleIdList": ["10.1038/s41598-017-05287-z", "PMC5505997", "28698611"]}, {"Citation": "Wang Z.H., Hsu C.C., Huang C.N., Yin M.C. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur. J. Pharmacol. 2010;628:255\u2013260. doi: 10.1016/j.ejphar.2009.11.019.", "ArticleIdList": ["10.1016/j.ejphar.2009.11.019", "19917277"]}, {"Citation": "Jang S.M., Kim M.J., Choi M.S., Kwon E.Y., Lee M.K. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metabolism. 2010;59:512\u2013519. doi: 10.1016/j.metabol.2009.07.040.", "ArticleIdList": ["10.1016/j.metabol.2009.07.040", "19846180"]}, {"Citation": "Sudhahar V., Kumar S.A., Varalakshmi P. Role of lupeol and lupeol linoleate on lipemic\u2013oxidative stress in experimental hypercholesterolemia. Life Sci. 2006;78:1329\u20131335. doi: 10.1016/j.lfs.2005.07.011.", "ArticleIdList": ["10.1016/j.lfs.2005.07.011", "16216277"]}, {"Citation": "Giulivi C., Traaseth N.J., Davies K.J.A. Tyrosine oxidation products: Analysis and biological relevance. Amino Acids. 2003;25:227\u2013232. doi: 10.1007/s00726-003-0013-0.", "ArticleIdList": ["10.1007/s00726-003-0013-0", "14661086"]}, {"Citation": "Basran J., Efimov I., Chauhan N., Thackray S.J., Krupa J.L., Eaton G., Griffith G.A., Mowat C.G., Handa S., Raven E.L. The mechanism of formation of N-formylkynurenine by heme dioxygenases. J. Am. Chem. Soc. 2011;133:16251\u201316257. doi: 10.1021/ja207066z.", "ArticleIdList": ["10.1021/ja207066z", "PMC3210546", "21892828"]}, {"Citation": "Manzanares D., Rodriguez-Capote K., Liu S., Haines T., Ramos Y., Zhao L., Doherty-Kirby A., Lajoie G., Possmayer F. Modification of tryptophan and methionine residues is implicated in the oxidative inactivation of surfactant protein B. Biochemistry. 2007;46:5604\u20135615. doi: 10.1021/bi062304p.", "ArticleIdList": ["10.1021/bi062304p", "17425286"]}, {"Citation": "Taylor D.M., Gibbs B.F., Kabashi E., Minotti S., Durham H.D., Agar J.N. Tryptophan 32 potentiates aggregation and cytotoxicity of a copper/zinc superoxide dismutase mutant associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 2007;282:16329\u201316335. doi: 10.1074/jbc.M610119200.", "ArticleIdList": ["10.1074/jbc.M610119200", "17389599"]}, {"Citation": "Irvine G.B., El-Agnaf O.M., Shankar G.M., Walsh D.M. Protein aggregation in the brain: The molecular basis for Alzheimer\u2019s and Parkinson\u2019s diseases. Mol. Med. 2008;14:451\u2013464. doi: 10.2119/2007-00100.Irvine.", "ArticleIdList": ["10.2119/2007-00100.Irvine", "PMC2274891", "18368143"]}, {"Citation": "Gie\u03b2auf A., van Wickern B., Simat T., Steinhart H., Esterbauer H. Formation of N-formylkynurenine suggests the involvement of apolipoprotein B-100 centered tryptophan radicals in the initiation of LDL lipid peroxidation. FEBS Lett. 1996;389:136\u2013140. doi: 10.1016/0014-5793(96)00546-7.", "ArticleIdList": ["10.1016/0014-5793(96)00546-7", "8766816"]}, {"Citation": "R\u00f6hrig U.F., Awad L., Grosdidier A., Larrieu P., Stroobant V., Colau D., Cerundolo V., Simpson A.J., Vogel P., Van den Eynde B.J., et al. Rational design of indoleamine 2, 3-dioxygenase inhibitors. J. Med. Chem. 2010;53:1172\u20131189.", "ArticleIdList": ["20055453"]}, {"Citation": "Moldogazieva N.T., Mokhosoev I.M., Mel\u2019nikova T.I., Porozov Y.B., Terentiev A.A. Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases. Oxidative Med. Cell. Longev. 2019;2019:3085756. doi: 10.1155/2019/3085756.", "ArticleIdList": ["10.1155/2019/3085756", "PMC6710759", "31485289"]}, {"Citation": "Schalkwijk C.G., Stehouwer C.D.A. Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other AGE-related diseases. Physiol. Rev. 2019;100:407\u2013461. doi: 10.1152/physrev.00001.2019.", "ArticleIdList": ["10.1152/physrev.00001.2019", "31539311"]}, {"Citation": "Colzani M., De Maddis D., Casali G., Carini M., Vistoli G., Aldini G. Reactivity, selectivity, and reaction mechanisms of aminoguanidine, hydralazine, pyridoxamine, and carnosine as sequestering agents of reactive carbonyl species: A comparative study. ChemMedChem. 2016;11:1778\u20131789. doi: 10.1002/cmdc.201500552.", "ArticleIdList": ["10.1002/cmdc.201500552", "26891408"]}, {"Citation": "K\u00f6nig J., Jung T., Grune T. Protein carbonylation in aging and senescence. In: Ros J., editor. Protein Carbonylation: Principles, Analysis, and Biological Implications. Volume 1. John Wiley & Sons, Inc.; New York, NY, USA: 2017. pp. 272\u2013290."}, {"Citation": "Dalle-Donne I., Aldini G., Carini M., Colombo R., Rossi R., Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell. Mol. Med. 2006;10:389\u2013406. doi: 10.1111/j.1582-4934.2006.tb00407.x.", "ArticleIdList": ["10.1111/j.1582-4934.2006.tb00407.x", "PMC3933129", "16796807"]}, {"Citation": "Vistoli G., De Maddis D., Cipak A., Zarkovic N., Carini M., Aldini G. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation. Free Radic. Res. 2013;47((Suppl. 1)):3\u201327. doi: 10.3109/10715762.2013.815348.", "ArticleIdList": ["10.3109/10715762.2013.815348", "23767955"]}, {"Citation": "Emel\u2019yanov V.V. Glycation, antiglycation, and deglycation: Their role in aging mechanisms and geroprotective effects (literature review) Adv. Gerontol. 2017;7:1\u20139. doi: 10.1134/S2079057017010064.", "ArticleIdList": ["10.1134/S2079057017010064", "28525687"]}, {"Citation": "Liu T., Zhang L., Joo D., Sun S.C. NF-\u03baB signaling in inflammation. Signal Transduct. Target. Ther. 2017;2:1\u20139. doi: 10.1038/sigtrans.2017.23.", "ArticleIdList": ["10.1038/sigtrans.2017.23", "PMC5661633", "29158945"]}, {"Citation": "Shaklai N., Garlick R.L., Bunn H.F. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 1984;259:3812\u20133817. doi: 10.1016/S0021-9258(17)43168-1.", "ArticleIdList": ["10.1016/S0021-9258(17)43168-1", "6706980"]}, {"Citation": "Szkudlarek A., Maci\u0105\u017cek-Jurczyk M., Chudzik M., R\u00f3wnicka-Zubik J., Su\u0142kowska A. Alteration of human serum albumin tertiary structure induced by glycation: Spectroscopic study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2016;153:560\u2013565. doi: 10.1016/j.saa.2015.09.018.", "ArticleIdList": ["10.1016/j.saa.2015.09.018", "26433342"]}, {"Citation": "Okabe N., Hashizume N. Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism. Biol. Pharm. Bull. 1994;17:16\u201321. doi: 10.1248/bpb.17.16.", "ArticleIdList": ["10.1248/bpb.17.16", "8148809"]}, {"Citation": "Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., Curry S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 2005;353:38\u201352. doi: 10.1016/j.jmb.2005.07.075.", "ArticleIdList": ["10.1016/j.jmb.2005.07.075", "16169013"]}, {"Citation": "Roberts J.A., Pea F., Lipman J. The clinical relevance of plasma protein binding changes. Clin. Pharmacokinet. 2013;52:1\u20138. doi: 10.1007/s40262-012-0018-5.", "ArticleIdList": ["10.1007/s40262-012-0018-5", "23150213"]}, {"Citation": "Trynda-Lemiesz L., Wiglusz K. Effects of glycation on meloxicam binding to human serum albumin. J. Mol. Struct. 2011;995:35\u201340. doi: 10.1016/j.molstruc.2011.03.037.", "ArticleIdList": ["10.1016/j.molstruc.2011.03.037"]}, {"Citation": "Morais M.P.P., Mackay J.D., Bhamra S.K., Buchanan J.G., James T.D., Fossey J.S., van den Elsen J.M.H. Protein Electrophoresis. Humana Press; Totowa, NJ, USA: 2010. Analysis of protein glycation using phenylboronate acrylamide gel electrophoresis; pp. 93\u2013109.", "ArticleIdList": ["19899078"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "19"}, {"Year": "2023", "Month": "2", "Day": "6"}, {"Year": "2023", "Month": "2", "Day": "9"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "1", "Minute": "11"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["36830081", "PMC9952575", "10.3390/antiox12020522", "antiox12020522"]}}], "PubmedBookArticle": []}